Inactivation of the vitamin D receptor in APC min/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth

International Journal of Cancer

Volumn 130, Issue 1, 2012, Pages 10-19

  Zheng, Wei ^a,b   Wong, Kari E ^b   Zhang, Zhongyi ^b   Dougherty, Urzsula ^b   Mustafi, Reba ^b   Kong, Juan ^b,c   Deb, Dilip K ^b   Zheng, Huachuan ^c   Bissonnette, Marc ^b   Li, Yan Chun ^b,c  

^a Hunan Provincial People's Hospital   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

catenin; Apc min +; colon cancer; intestinal tumor; vitamin D receptor

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN D1; MESSENGER RNA; PROTEIN BCL 2; PROTEIN MSH2; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN 1; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; COLON CARCINOMA; COLON TUMOR; CONTROLLED STUDY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TUMOR; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SMALL INTESTINE TUMOR; TUMOR VOLUME;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; GENES, APC; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTESTINAL NEOPLASMS; MICE; MICE, INBRED C57BL; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 80255129256     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25992     Document Type: Article

References (47)

1. Morin PJ,. β-Catenin signaling and cancer. Bioessays 1999; 21: 1021-30.
2. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF,. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256: 668-70.
3. Newmark HL, Lipkin M,. Calcium, vitamin D, and colon cancer. Cancer Res 1992; 52: 2067s-2070s.
4. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED,. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 2: 1176-8. (Pubitemid 19275448)
5. Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E,. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 2000; 9: 1059-65.
6. Sadava D, Remer T, Petersen K,. Hyperplasia, hyperproliferation and decreased migration rate of colonic epithelial cells in mice fed a diet deficient in vitamin D. Biol Cell 1996; 87: 113-15. (Pubitemid 27033704)
7. Kawaura A, Tanida N, Sawada K, Oda M, Shimoyama T,. Supplemental administration of 1α-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis 1989; 10: 647-9. (Pubitemid 19101278)
8. Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, Kopelovich L, Edelmann W, Jin B, Gravaghi C, Augenlicht L, Kucherlapati R, et al. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J Nutr 2008; 138: 1658-63.
9. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A,. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000; 60: 2304-12. (Pubitemid 30225198)
10. Kumagai T, O'Kelly J, Said JW, Koeffler HP,. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 2003; 95: 896-905. (Pubitemid 36833881)
11. Ochs-Balcom HM, Cicek MS, Thompson CL, Tucker TC, Elston RC, Plummer SJ, Casey G, Li L,. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis 2008; 29: 1788-93.
12. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML,. Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 744-9.
13. Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, Martinez ME, Mount D, Jacobs ET,. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res 2010; 70: 1496-504.
14. Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, Campbell PT, Levine AJ, Limburg P, Le Marchand L, Cotterchio M, Newcomb PA, Potter JD, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2010; 19: 525-36.
15. Huerta S, Irwin RW, Heber D, Go VL, Koeffler HP, Uskokovic MR, Harris DM,. 1α,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res 2002; 62: 741-6. (Pubitemid 34126949)
16. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M, Munoz A,. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 2001; 154: 369-87. (Pubitemid 34286147)
17. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR,. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007; 446: 676-9. (Pubitemid 46606884)
18. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, et al. The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol Cell 2006; 21: 799-809. (Pubitemid 43376130)
19. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB,. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997; 94: 9831-5.
20. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB,. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998; 139: 4391-6. (Pubitemid 28513729)
21. Sitrin MD, Halline AG, Abrahams C, Brasitus TA,. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res 1991; 51: 5608-13.
22. Pence BC, Dunn DM, Zhao C, Landers M, Wargovich MJ,. Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis 1995; 16: 757-65.
23. Chakrabarty S, Radjendirane V, Appelman H, Varani J,. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res 2003; 63: 67-71. (Pubitemid 36070421)
24. Ruifrok AC, Johnston DA,. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 2001; 23: 291-9. (Pubitemid 32762920)
25. Li YC, Bolt MJG, Cao L-P, Sitrin MD,. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab 2001; 281: E558-E564.
26. Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, Beug H, Ohlschlager P, et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005; 7: 545-55. (Pubitemid 40967755)
27. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, Shah S, Byers SW, Mahmood R, Augenlicht LH, Russell R, Pestell RG,. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 2004; 24: 7598-611. (Pubitemid 39121486)
28. Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY,. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res 2000; 254: 279-86. (Pubitemid 30080584)
29. Wali RK, Bissonnette M, Khare S, Hart J, Sitrin MD, Brasitus TA,. 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1α,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res 1995; 55: 3050-4.
30. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS,. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 2001; 22: 1429-35. (Pubitemid 32898700)
31. Oyama T, Yamada Y, Hata K, Tomita H, Hirata A, Sheng H, Hara A, Aoki H, Kunisada T, Yamashita S, Mori H,. Further upregulation of β-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice. Carcinogenesis 2008; 29: 666-72. (Pubitemid 351404885)
32. Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA,. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res 2000; 60: 4602-9. (Pubitemid 32103646)
33. Tetsu O, McCormick F,. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6. (Pubitemid 29180374)
34. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T, Sekine I,. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 2005; 58: 833-8. (Pubitemid 41113390)
35. Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, Tauber S, Esterbauer H, Mueller M, Casanova E, Kenner L, Poli V, Eferl R,. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Gastroenterology 2010; 138: 1003-11.e1-1003-11.e5.
36. Stephanou A, Latchman DS,. Opposing actions of STAT-1 and STAT-3. Growth Factors 2005; 23: 177-82. (Pubitemid 43203048)
37. Liddle FJ, Frank DA,. STAT1 expression is not required for polyp formation in Min mice. Mol Carcinog 2008; 47: 75-9. (Pubitemid 351231435)
38. Peltomaki P,. Lynch syndrome genes. Fam Cancer 2005; 4: 227-32. (Pubitemid 41242191)
39. Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS,. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 2002; 40: 1191-6. (Pubitemid 34626885)
40. Polager S, Kalma Y, Berkovich E, Ginsberg D,. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 2002; 21: 437-46. (Pubitemid 34123806)
41. Chen X, Halberg RB, Burch RP, Dove WF,. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 2008; 39: 283-94.
42. Singh A, Settleman J,. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-51.
43. Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J,. Inhibitory effects of 1α,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 2001; 15: 1370-80. (Pubitemid 32703484)
44. Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP,. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142-53. (Pubitemid 26049905)
45. Philipp-Staheli J, Kim KH, Payne SR, Gurley KE, Liggitt D, Longton G, Kemp CJ,. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 2002; 1: 355-68. (Pubitemid 41039137)
46. Yang WC, Mathew J, Velcich A, Edelmann W, Kucherlapati R, Lipkin M, Yang K, Augenlicht LH,. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 2001; 61: 565-9. (Pubitemid 32128615)
47. Palmer HG, Larriba MJ, Garcia JM, Ordonez-Moran P, Pena C, Peiro S, Puig I, Rodriguez R, de la Fuente R, Bernad A, Pollan M, Bonilla F, et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004; 10: 917-19. (Pubitemid 39273731)